2025-11-11T13:08:03-06:00 2024-12-31 333709623 COHNREZNICK ADVISORY LLC 7501 WISCONSIN AVENUE SUITE 400E BETHESDA MD 20814 990 2024-01-01 833561693 ASCO ASSOCIATION ASCO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 MELINDA O'LEARY CFO 5714831700 2025-11-07 1 1 ZACHARY SEGAL P01511850 3016529100 2025-10-23 2024 2025-03-06 01:10:19Z ASSOCIATION FOR CLINICAL ONCOLOGY CLIFFORD HUDIS MD CEO 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 16561916 0 X WWW.ASCOASSOCIATION.ORG X 2019 VA OUR MISSION IS TO CONQUER CANCER THROUGH ADVOCACY FOR RESEARCH, EDUCATION, AND THE PROMOTION OF THE HIGHEST QUALITY PATIENT CARE. 10 10 50 4083 426142 230178 933505 90630 16132753 15943898 134364 330483 207674 196905 17408296 16561916 138592 127053 0 0 7273510 8638328 0 0 0 7643643 7420899 15055745 16186280 2352551 375636 5377567 27886472 12210976 34333269 -6833409 -6446797 X ASCO ASSOCIATION PROMOTES THE COMMON BUSINESS INTERESTS OF ITS MEMBERS BY: (1) ADVOCATING FOR POLICIES THAT IMPROVE THE QUALITY OF CANCER CARE; (2) MAINTAINING THE HIGHEST STANDARDS OF ONCOLOGY MEDICAL CARE THROUGH PROGRAMS SUPPORTING EDUCATION, (CONTINUED IN SCHEDULE O) RESEARCH, AND QUALITY IMPROVEMENT; AND (3) INCREASING AWARENESS AMONG THE MEDICAL COMMUNITY, PATIENTS, AND THE PUBLIC OF CHALLENGES FACED BY ONCOLOGY MEDICAL PROFESSIONALS THAT MAY AFFECT QUALITY OF CANCER CARE. 0 0 SEE SCHEDULE O:MEMBER SERVICES: THE ASSOCIATION WORKS TO SUPPORT AND EDUCATE ITS GLOBAL NETWORK OF NEARLY 51,000 ONCOLOGY PROFESSIONAL MEMBERS, MAINTAINING ONLINE FORUMS THAT ALLOW MEMBERS TO DISCUSS ISSUES OF PROFESSIONAL INTEREST, SUPPORTING INTERNATIONAL REGIONAL COUNCILS, AND RECRUITING MEMBERS FOR, AND TRACKING PARTICIPATION IN, VOLUNTEER ACTIVITIES RELATED TO THE ASSOCIATION, INCLUDING SERVING ON COMMITTEES. SEE SCHEDULE O:ACCREDITATION & CERTIFICATION: THE ASSOCIATION CONDUCTS AN ACCREDITATION PROGRAM THAT PROMOTES THE PRACTICE OF ITS MEMBERS BY MAINTAINING AND IMPROVING THE QUALITY OF MEDICAL CARE AVAILABLE TO THE PUBLIC AND MAINTAINING HIGH STANDARDS OF EXCELLENCE IN ONCOLOGY. THE QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) CERTIFICATION PROGRAM ("QCP") PROVIDES A THREE-YEAR CERTIFICATION RECOGNIZING HIGH-QUALITY AND SAFE CARE FOR OUTPATIENT HEMATOLOGY-ONCOLOGY PRACTICES. THE QCP STANDARDS WERE ADAPTED FROM THE CHEMOTHERAPY ADMINISTRATION SAFETY STANDARDS CODEVELOPED BY THE ASSOCIATION'S RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (THE SOCIETY), A SECTION 501(C)(3) ORGANIZATION, AND THE ONCOLOGY NURSING SOCIETY (ONS). THEY ARE INTENDED TO PROVIDE SAFTEY TO BOTH PATIENTS AND THE CARE DELIVERY STAFF BY REDUCING THE RISK OF ERRORS AND PROMOTING THE SAFE HANDLING OF CHEMOTHERAPY AGENTS. PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL QCP STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. QCP CERTIFICATION RECOGNIZES HIGH PERFORMING PRACTICES AND IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 272 HEMATOLOGY-ONCOLOGY PRACTICES CONSISTING OF 900 SITES OF SERVICE WERE ACTIVELY CERTIFIED IN 2024. THE ASCO CERTIFIED CERTIFICATION RECOGNIZES PATIENT-CENTERED CANCER CARE DELIVERY ADHERING TO THE ONCOLOGY MEDICAL HOME STANDARDS CODEVELOPED BY ASCO AND THE COMMUNITY ONCOLGY ALLIANCE (COA). SIMILAR TO QCP, PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL ASCO CERTIFIED STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. ONCE CERTIFIED, PARTICIPANTS ARE MONITORED ANNUALLY FOR CONTINUOUS QUALITY IMPROVEMENT AND RESURVEYED EVERY 3 YEARS. ASCO CERTIFIED IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 16 HEMATOLOGY ONCOLOGY PRACTICES CONSISTING OF 143 SITES OF SERVICE WERE CERTIFIED IN 2024. SEE SCHEDULE O:ADVOCACY: THE ASSOCIATION'S ADVOCACY WORK FOCUSES ON ACHIEVING HIGH-QUALITY CARE FOR ALL PATIENTS WITH CANCER. WORKING WITH VOLUNTEER MEMBERS AND AFFILIATED STATE AND REGIONAL ONCOLOGY SOCIETIES, THE ASSOCIATION ENGAGES WITH THE ADMINISTRATION, CONGRESS, AND STATE POLICYMAKERS TO ADDRESS ISSUES OF CRITICAL IMPORTANCE TO CANCER CARE AND RESEARCH. THE ASSOCIATION'S ADVOCACY PORTFOLIO INCLUDES CLINICAL RESEARCH, INSURANCE, CLINICAL PRACTICE, COST AND ACCESS, SURVIVORSHIP, INFORMATION TECHNOLOGY, AND CANCER PREVENTION. ADVOCACY ACTIVITIES INCLUDE TRACKING, MONITORING, ANALYZING, AND INFLUENCING PENDING LEGISLATION AND REGULATIONS, AND EDUCATING BOTH MEMBERS AND POLICYMAKERS ABOUT THE IMPACT OF POLICY ON CANCER PATIENTS, CLINICIANS, AND CLINICAL RESEARCH. THE ASSOCIATION'S PERSPECTIVE IS SOUGHT ROUTINELY BY POLICYMAKERS AS THEY ADDRESS CHALLENGES IN CANCER CARE AND RESEARCH. IN 2024, THE ASSOCIATION WAS INVITED TO TESTIFY BEFORE THE HOUSE WAYS AND MEANS COMMITTEE ON THE PERSISTENT AND ONGOING DRUG SHORTAGE CRISIS. THE ASSOCIATION WAS ALSO ONE OF ONLY SIX MEDICAL SOCIETIES INVITED TO A MEETING CONVENED BY THE SENATE FINANCE COMMITTEE TO EXPLORE POTENTIAL IMPROVEMENTS IN THE MEDICARE PHYSICIAN PAYMENT SYSTEM. IN APRIL OF 2024, THE ASSOCIATION CONVENED AN ADVOCACY SUMMIT WHERE 170 ONCOLOGY PROFESSIONALS CONDUCTED 220 VISITS WITH MEMBERS OF CONGRESS AND THEIR STAFF TO SHARE PERSPECTIVES. ADDITIONALLY, THE ASSOCIATION SENT OVER 300 COMMENT LETTERS TO CONGRESS, PROVIDED INPUT ON MORE THAN 60 STATE LEGISLATIVE PROPOSALS AND CONDUCTED 400 MEETINGS WITH MEMBERS OF CONGRESS AND THEIR STAFF FOR 2024. THE ASCO 2024 ANNUAL MEETING WAS THE FIRST ANNUAL MEETING TO HOST ALL THREE FEDERAL LEADERS OF THE PRIMARY AGENCIES OF RELEVANCE FOR CANCER RESEARCH AND CARE THE DIRECTOR OF THE NATIONAL INSTITUTES OF HEALTH, THE DIRECTOR OF THE NATIONAL CANCER INSTITUTE, AND THE COMMISSIONER OF THE U.S. FOOD AND DRUG ADMINISTRATION. THE ASSOCIATION ALSO HAD 47 MEETINGS WITH FEDERAL AGENCY STAFF AND LEADERS,SENT 25 COMMENT LETTERS IN RESPONSE TO FEDERAL PROPOSALS AND REGULATIONS, AND FILED 7 JOINT AMICUS BRIEFS TO THE COURTS. 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 20 0 1 50 1 1 1 0 0 0 1 1 0 0 0 X 10 10 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 0 VA X MELINDA O'LEARY CFO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 EVERETT E VOKES MD BOARD CHAIR (PARTIAL YEAR) 1.00 1.00 X X 0 0 0 ERIC P WINER MD BOARD CHAIR (PARTIAL YEAR) 1.00 1.00 X X 0 0 0 BRIAN EDWARD PERSING MD TREASURER (PARTIAL YEAR) 1.00 X X 0 0 0 MARTIN PALMERI TREASURER (PARTIAL YEAR) 1.00 X X 0 0 0 LISA A CAREY MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 MARIANA CHAVEZ MACGREGOR MD MSC BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 TARA O HENDERSON MD MPH BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 CAROLYN B HENDRICKS MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 TAOFEEK K OWONIKOKO MD PHD BOARD MEMBER 1.00 1.00 X 0 0 0 ELIZABETH R PLIMACK MD MS BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 GLADYS I RODRIGUEZ MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 LYNN M SCHUCHTER MD BOARD MEMBER 1.00 1.00 X 0 0 0 ERIC J SMALL MD BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 ENRIQUE SOTO PEREZ DE CELIS MD MSC BOARD MEMBER (PARTIAL YEAR) 1.00 1.00 X 0 0 0 PIYUSH SRIVASTAVA MD BOARD MEMBER (PARTIAL YEAR) 1.00 X 0 0 0 EMILY TOULOUKIAN BOARD MEMBER (PARTIAL YEAR) 1.00 X 0 0 0 ROBIN ZON MD BOARD MEMBER 1.00 1.00 X 0 0 0 CLIFFORD A HUDIS MD CEO 1.00 36.50 X 0 1114041 25875 MELINDA O'LEARY CFO (PARTIAL YEAR) 6.50 31.00 X 0 259970 24887 MELISSA TAI ESQ SECRETARY 8.00 29.50 X 0 369986 55293 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 19.00 18.50 X 311755 0 52830 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 37.50 X 265455 0 49047 KAREN HAGERTY MD CHIEF REGULATORY AFFAIRS OFFICER 37.50 X 236405 0 27627 RONDA BOWMAN SENIOR DIRECTOR, QCP 37.50 X 226306 0 33850 TERRY COX DIRECTOR, AFFILIATE RELATIONS 37.50 X 174961 0 34983 ERIC HAMP SENIOR DIRECTOR, MEMBERSHIP 37.50 X 172539 0 41955 KRISTINE RUFENER DIRECTOR, CONGRESSIONAL AFFAIRS 37.50 X 182139 0 43390 1569560 1743997 389737 25 0 1 0 WOLTERS KLUWER HEALTH 351 WEST CAMDEN ST BALTIMORE MD 21201 DESIGN, PRINT, MAIL 1268350 TIBER CREEK GROUP INC 750 9TH ST NW SUITE 501 WASHINGTON DC 20001 PUBLIC AFFAIRS 180000 MCI GROUP ASIA PACIFIC PTE LTD 20 BENDEMEER RD 04-02 SN 339914 MARKETING 128000 3 90630 90630 MEMBER DUES 813920 14084522 14084522 CERTIFICATION INCOME 813920 793211 793211 MEMBER SERVICES 813920 640023 640023 ADVERTISING 541800 426142 426142 15943898 330483 330483 196905 196905 16561916 15517756 426142 527388 127053 679089 6228968 427298 797486 505487 39019 47691 180000 1531616 91658 305380 456315 479847 707959 3531 67342 39284 PRINTING, POSTAGE & PRO 2831974 BANK & CREDIT CARD FEES 568322 UBI TAX 22523 48438 16186280 3380533 13926016 171520 12084822 42173 1783341 1875634 5377567 27886472 454050 527926 11277996 11489397 478930 22315946 12210976 34333269 X -6833409 -6446797 -6833409 -6446797 5377567 27886472 375636 10976 0 X X 0 1 X 1 0 0 0 0 14084522 384767 384767 1267607 -882840 0 DUE TO AFFILIATES 22315946 22315946 X PART X, LINE 2: IN PART: THE ASSOCIATION IS A NON-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(6) OF THE IRC AS A TRADE ASSOCIATION. QCP IS A DISREGARDED ENTITY AND INCLUDED IN THE ASSOCIATION'S INCOME TAX RETURN. THE PAC IS A SEPARATE SEGREGATED FUND OF THE ASSOCIATION CLASSIFIED UNDER SECTION 527 OF THE IRC. THE ASSOCIATION RECEIVED TAXABLE REVENUE RELATED TO ADVERTISING. THE ORGANIZATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. GENERALLY, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2021. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES MEMBERSHIP SERVICES 129518 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES & MEMBERSHIP SERVICES 56725 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES & MEMBERSHIP SERVICES 14824 SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, 0 0 PROGRAM SERVICES INTERNATIONAL MEETINGS 1682 NORTH AMERICA 0 0 PROGRAM SERVICES MEMBERSHIP SERVICES 539 SOUTH ASIA 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 313 0 0 0 0 0 0 203601 0 203601 0 0 0 0 0 1 PART I, LINE 3: THE ACCRUAL METHOD IS USED TO TRACK AND ACCOUNT FOR FOREIGN EXPENDITURES. 1 YALE UNIVERSITY PO BOX 208239 NEW HAVEN CT 06520 060646973 501(C)(3) 30000 0 SUPPORT FOR SCHOOL OF MEDICINE 1 0 PART I, LINE 2: GRANTS ARE MADE TO SELECT ORGANIZATIONS WHOSE MISSION INVOLVES CANCER CARE, EDUCATION OR RESEARCH. GRANTS ARE DESIGNATED FOR SCIENTIFIC, EDUCATIONAL OR RESEARCH PURPOSES. 0 0 0 CLIFFORD A HUDIS MD CEO 0 1101755 0 10000 0 2286 0 25875 0 0 0 1139916 0 0 MELISSA TAI ESQ SECRETARY 0 357716 0 12000 0 270 0 25875 0 29418 0 425279 0 0 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 300891 0 10450 0 414 0 23250 0 29580 0 364585 0 0 0 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 253537 0 11504 0 414 0 19467 0 29580 0 314502 0 0 0 MELINDA O'LEARY CFO (PARTIAL YEAR) 0 259731 0 0 0 239 0 19616 0 5271 0 284857 0 0 KAREN HAGERTY MD CHIEF REGULATORY AFFAIRS OFFICER 224109 0 11522 0 774 0 16890 0 10737 0 264032 0 0 0 RONDA BOWMAN SENIOR DIRECTOR, QCP 212520 0 11500 0 2286 0 16380 0 17470 0 260156 0 0 0 KRISTINE RUFENER DIRECTOR, CONGRESSIONAL AFFAIRS 172227 0 9750 0 162 0 13810 0 29580 0 225529 0 0 0 ERIC HAMP SENIOR DIRECTOR, MEMBERSHIP 158977 0 13400 0 162 0 12375 0 29580 0 214494 0 0 0 TERRY COX DIRECTOR, AFFILIATE RELATIONS 173047 0 1500 0 414 0 13500 0 21483 0 209944 0 0 0 PART I, LINE 3 COMPENSATION FOR THE CEO IS ESTABLISHED BY THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO), A SECTION 501(C)(3) ORGANIZATION. THE METHODS USED BY THE SOCIETY IN DETERMINING THE CEO'S COMPENSATION INCLUDE COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, FORM 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD AND COMPENSATION COMMITTEE. UNDER A SHARED SERVICES AGREEMENT BETWEEN THE SOCIETY AND THE ASSOCIATION, THE ASSOCIATION PAYS THE SOCIETY FOR TIME SPENT BY THE CEO ON ASSOCIATION MATTERS. FORM 990, PART VI, SECTION A, LINE 1A DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH THE ASSOCIATION'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE THE CHAIR, TREASURER, AND ONE OR MORE VOTING MEMBERS OF THE BOARD OF DIRECTORS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF THE ASSOCIATION'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY THE ASSOCIATION'S EXECUTIVE COMMITTEE CHARTER, WHICH WAS APPROVED BY THE ASSOCIATION'S BOARD OF DIRECTORS. THE CHARTER PROVIDES THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY THE BYLAWS, RESOLUTION OF THE BOARD OF DIRECTORS, OR APPLICABLE LAW, THE EXECUTIVE COMMITTEE IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 6 NONE OF THE ASSOCIATION'S MEMBERS HAS THE RIGHT TO RECEIVE A SHARE OF THE ORGANIZATION'S PROFITS OR EXCESS DUES OR A SHARE OF THE ORGANIZATION'S NET ASSETS UPON DISSOLUTION. MEMBERSHIP IS LIMITED TO ONCOLOGY MEDICAL PROFESSIONALS, DEFINED AS INDIVIDUALS WHOSE PROFESSIONAL CREDENTIALS AND ACTIVITIES INVOLVE CANCER PATIENT CARE AND/OR RESEARCH, EDUCATION, OR ADVOCACY IN THE BIOLOGY, DIAGNOSIS, PREVENTION, OR TREATMENT OF HUMAN CANCER; THOSE INDIVIDUALS WHO ARE RETIRED FROM PROFESSIONAL ACTIVITIES, BUT WHOSE PROFESSIONAL ACTIVITIES PRIOR TO RETIREMENT INCLUDED THOSE DESCRIBED ABOVE; AND THOSE INDIVIDUALS WHO ARE STUDENTS TRAINING TO BE PROFESSIONALS DESCRIBED ABOVE. THE CATEGORY OF MEMBERSHIP WITH VOTING RIGHTS IS VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7A ALL ASCO MEMBERS ARE MEMBERS OF BOTH THE ASSOCIATION AND ITS AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). VOTING MEMBERS OF ASCO ELECT ALL MEMBERS OF THE SOCIETY BOARD OF DIRECTORS. THE MEMBERS OF THE SOCIETY BOARD OF DIRECTORS WHO ARE IN THE FINAL YEAR OF THEIR TERMS, AND THE SOCIETY'S ELECTED OFFICERS, WHO ARE ALL ELECTED BY THE ASCO VOTING MEMBERS, SERVE AS EX-OFFICIO VOTING MEMBERS OF THE ASSOCIATION BOARD OF DIRECTORS. THE CATEGORY OF ASCO MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE SOCIETY BOARD OF DIRECTORS ARE VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7B VOTING MEMBERS HAVE THE RIGHT TO VOTE ON CHANGING THE PURPOSE OF THE ASSOCIATION (AS SET FORTH IN THE BYLAWS), VOLUNTARY DISSOLUTION OF THE ASSOCIATION, AND ANY SUCH MATTERS THAT THE BOARD OF DIRECTORS BRINGS TO THE MEMBERSHIP FOR VOTE. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT ELECTRONIC COPY OF THE ASSOCIATION'S FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS. IN ADDITION, BEFORE FILING, THE FORM WAS REVIEWED BY THE CFO AND CHIEF LEGAL OFFICER. FORM 990, PART VI, SECTION B, LINE 12C THE ASSOCIATION MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASSOCIATION MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. THE ASSOCIATION'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF THE ASSOCIATION WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. A BOARD MEMBER, DIRECTOR, PRINCIPAL OFFICER, OR KEY EMPLOYEE WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15B COMPENSATION OF THE SECRETARY, CHIEF FINANCIAL OFFICER, AND VICE PRESIDENT, MEMBER SERVICES WAS REVIEWED AND APPROVED USING COMPARABILITY DATA. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR EACH OF THE POSITIONS WAS REASONABLE. THIS REVIEW WAS LAST CONDUCTED IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ASSOCIATION'S ARTICLES OF INCORPORATION ARE AVAILABLE ON THE VIRGINIA STATE CORPORATION COMMISSION WEBSITE. THE ASSOCIATION MAKES ITS BYLAWS AVAILABLE UPON REQUEST. THE ASSOCIATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE ON THE ASCO WEBSITE. THE ASSOCIATION'S FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER OF THE ASSOCIATION IS AN EMPLOYEE OF THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). INFORMATION REGARDING HIS COMPENSATION AND THE PROCESS FOR DETERMINING HIS COMPENSATION, INCLUDING REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, ARE DESCRIBED IN THE IRS FORM 990 OF THE SOCIETY. THE ASSOCIATION REIMBURSES THE SOCIETY FOR TIME SPENT ON ASSOCIATION MATTERS IN ACCORDANCE WITH A SHARED SERVICES AGREEMENT BETWEEN THE ENTITIES. QOPI CERTIFICATION PROGRAM LLC 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 271629211 ACCREDITATION VA 808211 1920214 ASCO ASSOCIATION AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 136180380 RESEARCH/EDUCATION NY 501(C)(3) LINE 10 N/A 0 CONQUER CANCER FOUNDATION OF ASCO 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 311667995 GRANTS VA 501(C)(3) LINE 7 ASCO 0 ASCO ASSOCIATION POLITICAL ACTION COMM 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 844213157 ADVOCACY VA 527 ASCO ASSOC 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 0 0